Pulse Biosciences (PLSE) Accumulated Depreciation (2015 - 2025)

Pulse Biosciences' Accumulated Depreciation history runs 11 years deep, the most recent figure standing at $4.4 million for Q4 2025.

• In Q4 2025, Accumulated Depreciation rose 10.23% year-over-year to $4.4 million; the TTM figure through Dec 2025 stood at $4.4 million (up 10.23% YoY), while the FY2025 annual figure was $4.4 million, up 10.23% from the prior year.
• Accumulated Depreciation was $4.4 million for Q4 2025 at Pulse Biosciences, up from $4.3 million in the prior quarter.
• In the past five years, Accumulated Depreciation ranged from a high of $4.4 million in Q4 2025 to a low of $2.0 million in Q1 2021.
• Historically, Accumulated Depreciation has averaged $3.3 million across 5 years, with a median of $3.3 million in 2023.
• The sharpest annual moves came in 2022 and 2025: Accumulated Depreciation advanced 28.74% in 2022, then climbed 10.23% in 2025.
• A 5-year view of Accumulated Depreciation shows it stood at $2.4 million in 2021, then advanced by 23.25% to $3.0 million in 2022, then rose by 17.71% to $3.5 million in 2023, then grew by 14.15% to $4.0 million in 2024, then gained by 10.23% to $4.4 million in 2025.
• The last three Accumulated Depreciation figures came in at $4.4 million (Q4 2025), $4.3 million (Q3 2025), and $4.2 million (Q2 2025), per Business Quant data.